Decreased agonist sensitivity of human GABA(A) receptors by an amino acid variant, isoleucine to valine, in the alpha1 subunit.
Recombinant human GABA(A) receptors were investigated in vitro by coexpression of cDNAs coding for alpha1, beta2, and gamma2 subunits in the baculovirus/Sf-9 insect cell system. We report that a single amino acid exchange (isoleucine 121 to valine 121) in the N-terminal, extracellular part of the alpha1 subunit induces a marked decrease in agonist GABA(A) receptor ligand sensitivity. The potency of muscimol and GABA to inhibit the binding of the GABA(A) receptor antagonist [3H]SR 95531 (2-(3-carboxypropyl)-3-amino-6-(4-methoxyphenyl)pyridazinium bromide) was higher in receptor complexes of alpha1(ile 121) beta2gamma2 than in those of alpha1(val 121) beta2gamma2 (IC50 values were 32-fold and 26-fold lower for muscimol and GABA, respectively). The apparent affinity of the GABA(A) receptor antagonist bicuculline methiodide to inhibit the binding of [3H]SR 95531 did not differ between the two receptor complex variants. Electrophysiological measurements of GABA induced whole-cell Cl- currents showed a ten-fold decrease in the GABA(A) receptor sensitivity of alpha1 (val 121) beta2gamma2 as compared to alpha1(ile 121) beta2gamma2 receptor complexes. Thus, a relatively small change in the primary structure of the alpha1 subunit leads to a decrease selective for GABA(A) receptor sensitivity to agonist ligands, since no changes were observed in a GABA(A) receptor antagonist affinity and benzodiazepine receptor binding.
Westh-Hansen
S E
SE
The Research Institute of Biological Psychiatry, St. Hans Hospital, Roskilde, Denmark.
Rasmussen
P B
PB
Hastrup
S
S
Nabekura
J
J
Noguchi
K
K
Akaike
N
N
Witt
M R
MR
Nielsen
M
M
D016367:Baculoviridae / Q000235:genetics; D002460:Cell Line; D017931:DNA Primers; D018755:GABA Agonists / Q000494:pharmacology; D018756:GABA Antagonists / Q000378:metabolism / Q000494:pharmacology; D058785:GABA-A Receptor Agonists; D006801:Humans; D007532:Isoleucine / Q000235:genetics*; D018408:Patch-Clamp Techniques; D017354:Point Mutation; D011724:Pyridazines / Q000378:metabolism; D011963:Receptors, GABA-A / Q000235:genetics / Q000378:metabolism; D011994:Recombinant Proteins / Q000819:agonists / Q000235:genetics / Q000378:metabolism; D014633:Valine / Q000235:genetics*
D017931:DNA Primers; D018755:GABA Agonists; D018756:GABA Antagonists; D058785:GABA-A Receptor Agonists; D011724:Pyridazines; D011963:Receptors, GABA-A; D011994:Recombinant Proteins; D007532:Isoleucine; C049853:gabazine; D014633:Valine